相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EVALUATING THE ROLE OF SUBSTANCE P IN THE GROWTH OF BRAIN TUMORS
E. Harford-Wright et al.
NEUROSCIENCE (2014)
NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer
Kate M. Lewis et al.
ANTI-CANCER DRUGS (2013)
Substance P as a Mediator of Neurogenic Inflammation after Balloon Compression Induced Spinal Cord Injury
Anna V. Leonard et al.
JOURNAL OF NEUROTRAUMA (2013)
Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours
Kate M. Lewis et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Automatic Nonsubjective Estimation of Antigen Content Visualized by Immunohistochemistry Using Color Deconvolution
Stephen C. Helps et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke
Renee J. Turner et al.
BRAIN RESEARCH (2011)
Corticosteroids in brain cancer patients: benefits and pitfalls
Jörg Dietrich et al.
Expert Review of Clinical Pharmacology (2011)
The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines
Miguel Munoz et al.
LABORATORY INVESTIGATION (2010)
Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury
Elizabeth Harford-Wright et al.
NEUROSCIENCE LETTERS (2010)
Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions
Timothy L. Siu et al.
Cancers (2010)
Cellular characterization of the peritumoral edema zone in malignant brain tumors
Tobias Engelhorn et al.
CANCER SCIENCE (2009)
Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression
Francisco Esteban et al.
HISTOPATHOLOGY (2009)
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury
James J. Donkin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Dexamethasone for intracranial neurosurgery and anaesthesia
Brad Hockey et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas
Toshimasa Akazawa et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Pharmacological characterization of T-2328, 2-fluoro-4 '-methoxy-3 '-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyll][1,1 '-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor
Yurni Watanabe et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
The NK-1 Receptor Is Expressed in Human Primary Gastric and Colon Adenocarcinomas and Is Involved in the Antitumor Action of L-733,060 and the Mitogenic Action of Substance P on Human Gastrointestinal Cancer Cell Lines
Marisa Rosso et al.
TUMOR BIOLOGY (2008)
Tachykinins and their receptors in human malignancies
Carla Palma
CURRENT DRUG TARGETS (2006)
Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines
M Muñoz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Molecular mechanisms of brain tumor edema
MC Papadopoulos et al.
NEUROSCIENCE (2004)
The treatment of brain metastases in melanoma patients
D Bafaloukos et al.
CANCER TREATMENT REVIEWS (2004)
Cellular mechanisms of neurogenic inflammation
JD Richardson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Substance P
S Harrison et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
分享论文
